3-({[(4-Oxo-4H-chromen-2-yl)carbonyl]amino}ethyl)phenylethyl(methyl)carbamate

ID: ALA4173608

Chembl Id: CHEMBL4173608

PubChem CID: 145950384

Max Phase: Preclinical

Molecular Formula: C22H22N2O5

Molecular Weight: 394.43

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCN(C)C(=O)Oc1cccc(CCNC(=O)c2cc(=O)c3ccccc3o2)c1

Standard InChI:  InChI=1S/C22H22N2O5/c1-3-24(2)22(27)28-16-8-6-7-15(13-16)11-12-23-21(26)20-14-18(25)17-9-4-5-10-19(17)29-20/h4-10,13-14H,3,11-12H2,1-2H3,(H,23,26)

Standard InChI Key:  TWEUHVZHTLEEIL-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4173608

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 394.43

Molecular Weight (Monoisotopic): 394.1529

AlogP: 3.22

#Rotatable Bonds: 6

Polar Surface Area: 88.85

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 2.80

CX LogD: 2.80

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.69

Np Likeness Score: -0.83

References

1. Nesi G, Chen Q, Sestito S, Digiacomo M, Yang X, Wang S, Pi R, Rapposelli S..  (2017)  Nature-based molecules combined with rivastigmine: A symbiotic approach for the synthesis of new agents against Alzheimer's disease.,  141  [PMID:29031070] [10.1016/j.ejmech.2017.10.006]

Source

Source(1):

• Scientific Literature